BEUDAMED
    10 results · 21ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

    DISPOSIBLE EEG NEEDLE ELECTRODES

    FDA 510(k)
    FDA Class 2 ·Neurology

    LARGE CUP BIOPSY FORCEPS INSERT

    FDA UDI
    SONTEC INSTRUMENTS, INC.·B09929012800·LARGE CUP BIOPSY FORCEPS SINGLE-ACTION JAWS FOR...

    Sklar®

    FDA UDI
    SKLAR CORPORATION·10649111230950·SIMS SCISS STR S/S 8"

    FREEDOM TOTAL KNEE CRUCIATE RETAINING (CR) FEMORAL COMPONENT

    FDA 510(k)
    FDA Class 2 ·Orthopedic

    COMFIT POWDER FREE POLYMER COATED LATEX EXAMINATION GLOVE, NON STERILE WITH PROTEIN LABELING CLAIM (50 MICROGRAMS OR LES

    FDA 510(k)
    FDA Class 1 ·General Hospital

    DEXTRUS 4136

    FDA Adverse Event
    Injury ·BIOTRONIK SE & CO. KG·Product code NVZ·November 9, 2010

    PELVICOL 6X8 CM

    FDA Adverse Event
    Injury ·COVIDIEN, FORMERLY TISSUE SCIENCE LABORATORIES, PLC·Product code FTL·November 16, 2012

    OT ULTRALINK METER

    FDA Adverse Event
    Malfunction ·LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL·Product code NBW·June 30, 2014

    Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

    FDA Enforcement
    Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

    OPTETRAK Comprehensive Knee System including OPTETRAK RBK PS Tibial Components. NOTE: Information reflects Exactech recall expansion initiated on 02/07/2022.

    FDA Enforcement
    Class II ·Ongoing·Exactech, Inc.·October 13, 2021